Skip to main content
Molecular Medicine logoLink to Molecular Medicine
. 2000 Apr;6(4):251–267.

Insulin-like growth factor I and urokinase-type plasminogen activator bioregulation system as a survival mechanism of prostate cancer cells in osteoblastic metastases: development of anti-survival factor therapy for hormone-refractory prostate cancer.

M Koutsilieris 1, C Mitsiades 1, A Sourla 1
PMCID: PMC1949949  PMID: 10949907

Full Text

The Full Text of this article is available as a PDF (131.5 KB).


Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ

RESOURCES